The Saudi Genome Program, inaugurated by His Royal Highness, Prince Mohammed bin Salman bin Abdulaziz, Crown Prince, Prime Minister, and Chairman of the Council of Economic and Development Affairs, is one of the frontier national projects under Vision 2030, aiming to reduce the incidence of genetic diseases using advanced genomic technologies.
The Saudi Genome Program (SGP) will create a database to document the first genetic map of the Saudi society, develop personalized medicine practice, reduce the cost of healthcare, and improve quality of life.
The program supports healthcare provision through better diagnosis, therapy, and prevention. Major outcomes will include the implementation of premarital and newborn screening, cancer screening and targeted therapy, and better management of other multifactorial genetic diseases such as diabetes and loss of vision/hearing.
Using advanced genomic technologies for diagnosis and treatment and building capabilities in the field of genomics and big data analytics, will allow the Kingdom to gain a global position in the field of genomics research, capitalize on big data and artificial intelligence tools and mainstream personalized medicine.
Building a Saudi genetic database.
Reducing and preventing the spread of genetic diseases in the Kingdom.
Enabling scientists and researchers to benefit from a database of genetic information.
Studying genetic variants and developing diagnostic and preventative tools to reduce the incidence of genetic diseases.
Establishing advanced infrastructure in the fields of genomics and bioinformatics
Pathogenic variants identified, 3,000 of which are novel mutations causing 1,230 rare genetic disorders
Gene panels developed
Peer-reviewed papers published in international journals
Saudi research centers working in collaboration